Titlebook: Aging and Heart Failure; Mechanisms and Manag Bodh I. Jugdutt Book 2014 Springer Science+Business Media New York 2014 aging.heart failure.m

Hoover

書目名稱Aging and Heart Failure影響因子(影響力)




書目名稱Aging and Heart Failure影響因子(影響力)學(xué)科排名




書目名稱Aging and Heart Failure網(wǎng)絡(luò)公開度




書目名稱Aging and Heart Failure網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Aging and Heart Failure被引頻次




書目名稱Aging and Heart Failure被引頻次學(xué)科排名




書目名稱Aging and Heart Failure年度引用




書目名稱Aging and Heart Failure年度引用學(xué)科排名




書目名稱Aging and Heart Failure讀者反饋




書目名稱Aging and Heart Failure讀者反饋學(xué)科排名

Herbivorous

PLE

Hypertension and Prevention of Diastolic Heart Failure in the Aging Population,eart failure (HF). The prevalence of a normal left ventricular (LV) ejection fraction (EF) associated with HF or diastolic HF (DHF) increases with age, is higher in older women than in older men, and is present in approximately half of older HF patients. Hypertension is more common in patients with

泥瓦匠

d-limonene

grenade

Optimizing Therapy of Heart Failure in the Aging Population with Monitoring in Clinics,cts <1 % of adults under 50 years of age, but in patients over 80, the prevalence exceeds 10 %. Optimizing heart failure therapy in clinics under the guidance of multidisciplinary management teams has been shown to reduce readmission rates and mortality. Several contemporary randomized trials have s

我的巨大

Cardiac Alterations in Aging, Hypertension, and Diastolic Heart Failure,endent risk factor of CVD, in part due to progressive exposure to a variety of insults including smoking, obesity, hypertension (HTN), and chronic diseases. Population studies on aging demonstrate linear increases in systolic blood pressure throughout each decade of life. HTN is the most commonly id

墻壁

看法等

一夫一妻制

Biomarkers and Optimal Management of Heart Failure in the Aging Population,predispose the elderly to developing HF and small insults may rapidly precipitate decompensation of symptoms. There are special challenges in diagnosing and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-